Trademarkia Logo

Australia

AU$
BIOPROGNOSIS
Cancelled: Cancelled at the request of IB

Last updated on 11 Jun 2024

Owner Info

Renalytix AI, Inc.

1460 Broadway

New York NY 10036, UNITED STATES OF AMERICA

Serial Number

2323859 filed on 11 Jan 2022

Correspondent

Cooley LLP, Susan Piascik Christoff Cooley LLP

1299 Pennsylvania Ave., NW, Suite 700,

Washington DC 20004,

UNITED STATES OF AMERICA

BIOPROGNOSIS

Classification Information


Class [042]
Development of new technology for others in the field of medical devices and medical diagnostic apparatuses for predicting, identifying and determinin Read More

Mark Details


Serial Number

2323859

Registered On

NA

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

12 Jul 2021

Mark Type

US

Legal History


Show more

Status DateAction Taken
11th Jun 2024Status change to Voided
3rd May 2024Application Accepted correspondence sent
3rd May 2024IP Right has been Examined
3rd May 2024IP Right Acceptance Published
3rd May 2024Status change to Accepted
3rd May 2024IP right goods and service classes updated
23rd Dec 2023IRDA - Opposition Still Possible Notice correspondence sent
26th Jan 2023Adverse report (examination) - Partial Refusal correspondence sent
25th Jan 2023IP Right has been Examined
9th Jan 2023Awaiting examination